[go: up one dir, main page]

MX2016011809A - Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos. - Google Patents

Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos.

Info

Publication number
MX2016011809A
MX2016011809A MX2016011809A MX2016011809A MX2016011809A MX 2016011809 A MX2016011809 A MX 2016011809A MX 2016011809 A MX2016011809 A MX 2016011809A MX 2016011809 A MX2016011809 A MX 2016011809A MX 2016011809 A MX2016011809 A MX 2016011809A
Authority
MX
Mexico
Prior art keywords
antibodies
methods
production
immunoassay utilizing
luminescent oxygen
Prior art date
Application number
MX2016011809A
Other languages
English (en)
Other versions
MX377772B (es
Inventor
J Li Jay
J Ledden David
Scott Cowden Eric
Lu Donglai
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Publication of MX2016011809A publication Critical patent/MX2016011809A/es
Publication of MX377772B publication Critical patent/MX377772B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76—Chemiluminescence; Bioluminescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Se describen un sistema de detección quimioluminiscente, así como kits y dispositivos microfluídicos que contienen los mismos. También se describen métodos de uso de los sistemas, kits, y dispositivos. El primero, segundo, y tercer anticuerpos o fragmento de enlace de los mismos pueden proporcionarse en cualquier forma que permita que estos anticuerpos/fragmentos de enlace funcionen de acuerdo con los conceptos inventivos actualmente descritos y reivindicados. Por ejemplo, cada uno del primero, segundo, y tercer anticuerpos/fragmentos de enlace pueden ser un anticuerpo/fragmento de enlace policlonal o un anticuerpo/fragmento de enlace monoclonal.
MX2016011809A 2014-03-26 2015-03-24 Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos. MX377772B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461970596P 2014-03-26 2014-03-26
PCT/US2015/022209 WO2015148479A1 (en) 2014-03-26 2015-03-24 Luminescent oxygen channeling immunoassay utilizing three antibodies and methods of production and use thereof

Publications (2)

Publication Number Publication Date
MX2016011809A true MX2016011809A (es) 2017-05-10
MX377772B MX377772B (es) 2025-03-11

Family

ID=54196294

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011809A MX377772B (es) 2014-03-26 2015-03-24 Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos.

Country Status (11)

Country Link
US (2) US20170176419A1 (es)
EP (2) EP3123151B1 (es)
JP (1) JP6596440B2 (es)
CN (1) CN106662532B (es)
AU (1) AU2015236288A1 (es)
CA (1) CA2942281C (es)
DK (2) DK3483593T3 (es)
ES (2) ES2884930T3 (es)
IL (1) IL247630A0 (es)
MX (1) MX377772B (es)
WO (1) WO2015148479A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10908154B2 (en) 2016-12-09 2021-02-02 Abbottt Point of Care Inc. Combined immunoassay and magnetic immunoassay systems and devices for extended range of sensitivity
US10935511B2 (en) 2016-12-09 2021-03-02 Abbott Point Of Care Inc. Ameliorated crosstalk immunoassay test device for determining a concentration of an analyte
EP3552019B1 (en) 2016-12-09 2020-12-02 Abbott Point of Care Inc. Combined immunoassay and magnetic immunoassay methods for extended range of sensitivity
US10514379B2 (en) * 2016-12-09 2019-12-24 Abbott Point Of Care Inc. Dual range cardiac troponin immunoassay devices and methods using immunosensor and magnetic immunosensor
CN116879544A (zh) 2016-12-09 2023-10-13 雅培医护站股份有限公司 使用免疫传感器和磁免疫传感器的扩展范围的免疫测定装置
WO2018107012A1 (en) 2016-12-09 2018-06-14 Abbott Point Of Care Inc. Crossover analytical systems and methods using an immunosensor and magnetic immunosensor
WO2019167128A1 (ja) * 2018-02-27 2019-09-06 株式会社 島津製作所 サンドイッチ型免疫測定法
JP7434144B2 (ja) * 2018-02-27 2024-02-20 株式会社島津製作所 ＡＰＰ６６９－ｘのＮ末端を特異的に認識する抗体、及び免疫測定法
JP7122454B2 (ja) * 2018-07-30 2022-08-19 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド ビオチンアッセイを実施するためのキット、マイクロ流体デバイス、および方法
US11287429B2 (en) 2018-09-25 2022-03-29 Siemens Healthcare Diagnostics Inc. Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurements
JP7345057B2 (ja) * 2019-08-29 2023-09-14 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド 使い捨ての多検体消耗品で流体サンプルを評価するデバイスおよび方法
CN113125415B (zh) * 2019-12-31 2025-08-22 科美博阳诊断技术(上海)有限公司 一种竞争性均相化学发光检测方法及其应用
CN113125706B (zh) * 2019-12-31 2025-07-08 科美博阳诊断技术(上海)有限公司 一种竞争性均相化学发光测定试剂盒及其应用
CN113125731B (zh) * 2019-12-31 2025-09-16 科美博阳诊断技术(上海)有限公司 一种竞争性均相化学发光测定试剂盒及其应用
CN113125418A (zh) * 2019-12-31 2021-07-16 科美诊断技术股份有限公司 一种均相化学发光检测方法及其应用
CN113125704B (zh) * 2019-12-31 2025-08-22 科美博阳诊断技术(上海)有限公司 一种均相化学发光测定试剂盒及其应用
CN113125416B (zh) * 2019-12-31 2025-08-22 科美博阳诊断技术(上海)有限公司 一种竞争性均相化学发光检测方法及其应用
EP4138918A4 (en) * 2020-04-24 2024-01-24 Siemens Healthcare Diagnostics Inc. Calibration and quality control reagents for use with immunoassays for antibodies
CN111781385B (zh) * 2020-08-19 2023-07-18 武汉生之源生物科技股份有限公司 一种NT-proBNP检测试剂盒及其制备方法
CN114544978A (zh) * 2022-03-04 2022-05-27 美康生物科技股份有限公司 一种igf-1检测试剂盒及其制备方法和检测方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
NO164622C (no) * 1988-05-11 1990-10-24 Tore Lindmo Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav.
WO1992002551A1 (en) 1990-08-02 1992-02-20 B.R. Centre Limited Methods for the production of proteins with a desired function
ATE246360T1 (de) * 1991-05-22 2003-08-15 Dade Behring Marburg Gmbh Partikel, die eine zusammensetzung beinhalten, die eine chemilumineszierende verbindung umfassen
US5340716A (en) 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
US6251581B1 (en) * 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
GB9326238D0 (en) * 1993-12-23 1994-02-23 Sinvent As Method of assay
US7285418B2 (en) * 1996-06-25 2007-10-23 Hytest Ltd. Method and kit for the diagnosis of troponin I
US6248546B1 (en) * 1998-03-09 2001-06-19 Diagnostic Systems Laboratories, Inc. Assay of IGFBP complex
US6703248B1 (en) * 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
DE10064827A1 (de) * 2000-12-22 2002-06-27 Dade Behring Marburg Gmbh Nachweisverfahren
US6551788B1 (en) * 2001-11-28 2003-04-22 Beckman Coulter, Inc. Particle-based ligand assay with extended dynamic range
US6764819B2 (en) * 2002-07-16 2004-07-20 Emp Biotech Gmbh Method for chemiluminescent detection
US20050170443A1 (en) * 2003-10-03 2005-08-04 Scantibodies Laboratory, Inc. Methods and use of binding components for improving assay specificity
WO2007001378A2 (en) * 2004-09-20 2007-01-04 Boston Microfluidics Microfluidic device for detecting soluble molecules
WO2006119203A2 (en) * 2005-04-29 2006-11-09 Beckman Coulter Fluorescence lateral flow immunoassay
US8124015B2 (en) * 2006-02-03 2012-02-28 Institute For Systems Biology Multiplexed, microfluidic molecular assay device and assay method
GB2436616A (en) * 2006-03-29 2007-10-03 Inverness Medical Switzerland Assay device and method
KR101424304B1 (ko) * 2006-09-21 2014-08-06 네스텍 소시에테아노님 희귀 순환세포 내의 다수의 신호전달인자를 검출하기 위한 항체 기반 분석법
MX338151B (es) * 2007-03-01 2016-04-05 Symphogen As Composiciones de anticuerpo recombinante anti-receptor de factor de crecimiento epidermico.
US7790401B2 (en) * 2007-08-06 2010-09-07 Siemens Healthcare Diagnostics Methods for detection of immunosuppressant drugs
US20090170218A1 (en) * 2008-01-02 2009-07-02 Dade Behring Inc. Methods for detection of cyclosporin a
WO2011087813A2 (en) * 2009-12-22 2011-07-21 University Of Washington Capillarity-based devices for performing chemical processes and associated systems and methods
US9678068B2 (en) * 2010-03-01 2017-06-13 Quanterix Corporation Ultra-sensitive detection of molecules using dual detection methods
US10088490B2 (en) * 2010-08-20 2018-10-02 Siemens Healthcare Diagnostics Inc. Assay for analytes using multiple receptors
CN102565381B (zh) * 2010-12-08 2014-06-18 中国科学院生态环境研究中心 导电微粒子介导电化学发光信号的免疫检测方法
CA2856382C (en) 2011-11-22 2020-07-14 Siemens Healthcare Diagnostics Inc. Devices containing dried reagents for reconstitution as calibration and/or quality control solutions, and methods of production and use thereof
US10371661B2 (en) * 2013-03-15 2019-08-06 Siemens Healthcare Diagnostics Inc. Luminescent oxygen channeling immunoassays utilizing electrochemical discharge of singlet oxygen and methods of production and use thereof
WO2014151450A1 (en) 2013-03-15 2014-09-25 Siemens Healthcare Diagnostics Inc. Microfluidic distributing device
WO2014151590A1 (en) 2013-03-15 2014-09-25 Siemens Healthcare Diagnostics Inc. Heterogeneous luminescent oxygen channeling immunoassays and methods of production and use thereof
DK2972245T3 (da) 2013-03-15 2020-09-07 Siemens Healthcare Diagnostics Inc Heterogene luminescerende oxygenkanaliserende immunoassays
DK3024851T3 (en) * 2013-07-25 2018-08-06 Cytomx Therapeutics Inc MULTI-SPECIFIC ANTIBODIES, MULTI-SPECIFICALLY ACTIVABLE ANTIBODIES, AND METHODS FOR USING IT
US20160320415A1 (en) * 2013-12-16 2016-11-03 Xen Biofluidx, Inc. Fast reconstituting reagent pellets

Also Published As

Publication number Publication date
IL247630A0 (en) 2016-11-30
CN106662532B (zh) 2019-12-13
DK3483593T3 (da) 2021-07-19
EP3123151A1 (en) 2017-02-01
MX377772B (es) 2025-03-11
US20170176419A1 (en) 2017-06-22
WO2015148479A1 (en) 2015-10-01
EP3123151A4 (en) 2017-03-22
CA2942281A1 (en) 2015-10-01
CA2942281C (en) 2023-03-14
DK3123151T3 (en) 2019-03-18
JP2017508971A (ja) 2017-03-30
US20210231647A1 (en) 2021-07-29
JP6596440B2 (ja) 2019-10-23
EP3123151B1 (en) 2018-11-28
US12366571B2 (en) 2025-07-22
AU2015236288A1 (en) 2016-09-15
EP3483593A1 (en) 2019-05-15
ES2884930T3 (es) 2021-12-13
CN106662532A (zh) 2017-05-10
ES2713428T3 (es) 2019-05-21
EP3483593B1 (en) 2021-04-28

Similar Documents

Publication Publication Date Title
MX2016011809A (es) Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos.
UY40829A (es) Anticuerpos anti-phf-tau y sus usos
NI201500103A (es) Anticuerpos cd47 que no agotan plaquetas ni glóbulos rojos y métodos de uso de los mismos.
MX2024005976A (es) Un anticuerpo anti-tigit, un anticuerpo anti-pvrig y un anticuerpo anti-pd-1 para usarse en el tratamiento de cancer.
MX2020009021A (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
CO2017005650A2 (es) Anticuerpos anti-interleucina-33
CR20170251A (es) Anticuerpos anti-c5 y métodos para su uso
CR20180153A (es) Receptores de antígenes quiméricos basados en anticuerpos de dominio simple y métodos de uso de estos
CO2017013331A2 (es) Terapias de combinación para enfermedades malignas hematológicas con anticuerpos anti-cd38 e inhibidores de survivina
MX2016012855A (es) Receptores de antigeno quimerico especifico de cd33 para inmunoterapia de cancer.
MX2021003549A (es) Anticuerpos dobles especificos.
BR112015022260A2 (pt) anticorpo monoclonal, polinucleotídeo, composição farmacêutica, fragmento isolado de tau, uso de um anticorpo, método de triagem de um agente e ácido nucleico
CO2018001525A2 (es) Método para determinar la porosidad asociada a la materia orgánica en un pozo o formación
NZ628314A (en) Cd47 antibodies and methods of use thereof
BR112016019866A2 (pt) terapias de combinação com anticorpos anti-cd38
MX2017001597A (es) Anticuerpos anti-pd-l1.
AR098465A1 (es) ANTICUERPOS ANTI-a-SINUCLEÍNA Y MÉTODOS DE UTILIZACIÓN
CL2019000658A1 (es) Anticuerpo que se une específicamente a pd-1 y fragmento funcional del mismo.
MX362075B (es) Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
CR20160338A (es) Anticuerpos y métodos de uso
CL2019000659A1 (es) Anticuerpo que se une específicamente a il-17a y fragmento funcional del mismo.
WO2015051320A3 (en) Anti-sox10 antibody systems and methods
BR112018007842A2 (pt) imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk)
EA201890739A1 (ru) Анти-s100a8 для лечения лейкемии
PE20190415A1 (es) Anticuerpos anti-basigin humanizados y uso de los mismos

Legal Events

Date Code Title Description
FG Grant or registration